[Prophylactic treatment of severe forms of hemophilia A with fraction I (AHG) and PAMBA].
D000328:Adult; D000418:Albumins / Q000494:pharmacology; D062365:Aminobenzoates / Q000627:therapeutic use*; D000614:Aminocaproates / Q000494:pharmacology; D000933:Antifibrinolytic Agents; D007611:Aprotinin / Q000494:pharmacology; D001792:Blood Platelets; D005169:Factor VIII / Q000627:therapeutic use; D005340:Fibrinogen / Q000627:therapeutic use; D005612:Freeze Drying; D005916:Globulins / Q000627:therapeutic use; D006406:Hematoma / Q000601:surgery; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010447:Peptide Hydrolases; D013916:Thrombelastography
D000418:Albumins; D062365:Aminobenzoates; D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D005916:Globulins; D005169:Factor VIII; D005340:Fibrinogen; D007611:Aprotinin; D010447:Peptide Hydrolases
Prophylaktische Behandlung schwerer Verlaufs-formen von Hämophilie A mit Fraktion I(AHG) und PAMBA.